Anti-proliferating effects of ginsenoside Rh2 on MCF-7 human breast cancer cells

International Journal of Oncology

Volumn 14, Issue 5, 1999, Pages 869-875

  Oh, Meesook ^a   Choi, Yung Hyun ^e   Choi, Sang Ho ^a   Chung, Hae Young ^a   Kim, Kyu Won ^a,b   Kim, Shin Il ^c   Kim, Dong Kyoo ^d   Kim, Nam Deuk ^a,b  

^a Pusan National University   (South Korea)

^b Pusan Cancer Research Center   (South Korea)

^c Korea Ginseng Corporation   (South Korea)

^d Inje University   (South Korea)

^e GEORGETOWN UNIVERSITY   (United States)

Author keywords

G1 arrest; Ginsenoside Rh2; MCF 7

Indexed keywords

ANTINEOPLASTIC AGENT; CARRIER PROTEIN; CDK2 PROTEIN, HUMAN; CDKN1A PROTEIN, HUMAN; CELL CYCLE PROTEIN; CYCLIN D; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLIN E DEPENDENT KINASE; CYCLIN E-DEPENDENT KINASE; CYCLINE; DNA BINDING PROTEIN; E2F1 PROTEIN, HUMAN; GINSENOSIDE; GINSENOSIDE RH 2; PROTEIN SERINE THREONINE KINASE; RETINOBLASTOMA BINDING PROTEIN 1; RETINOBLASTOMA PROTEIN; SAPONIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR DP1; TRANSCRIPTION FACTOR E2F; TRANSCRIPTION FACTOR E2F1;

APOPTOSIS; ARTICLE; BREAST TUMOR; CELL CULTURE; CELL CYCLE G1 PHASE; CELL DIVISION; CHEMISTRY; DRUG EFFECT; GINSENG; HUMAN; MEDICINAL PLANT; METABOLISM; PATHOLOGY; PHOSPHORYLATION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BREAST NEOPLASMS; CARRIER PROTEINS; CDC2-CDC28 KINASES; CELL CYCLE PROTEINS; CELL DIVISION; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASES; CYCLINS; DNA-BINDING PROTEINS; E2F TRANSCRIPTION FACTORS; E2F1 TRANSCRIPTION FACTOR; G1 PHASE; GINSENOSIDES; HUMANS; PANAX; PHOSPHORYLATION; PLANTS, MEDICINAL; PROTEIN-SERINE-THREONINE KINASES; RETINOBLASTOMA PROTEIN; SAPONINS; TRANSCRIPTION FACTOR DP1; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 0033126998     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.14.5.869     Document Type: Article

References (31)

1. Ota T, Fujikawa-Yamamoto K, Zong ZP, Yamazaki M, Odashima S, Kitagawa I, Abe H and Arichi S: Plant-glycoside modulation of cell surface related to control of differentiation cultured B16 melanoma cells. Cancer Res 47: 3863-3867, 1987.
2. Ota T, Maeda M and Odashima S: Mechanism of action of ginsenoside Rh2: uptake and metabolism of ginsenoside Rh2 by cultured B16 melanoma cells. J Pharm Sci 80: 1141-1146, 1991.
3. Kitagawa I, Yoshikawa M, Yoshihara M, Hayashi T and Toniyama T: Chemical studies on crude drugs. I. Constituents of Ginseng radix rubra. Yakueaku Zasshi 103: 612-622, 1983.
4. Odashima S, Nakayabu Y, Honjo N, Abe H and Arichi S: Induction of phenotypic reverse transformation by ginsenosides in cultured Morris hepatoma cells. Eur J Cancer 15: 885-892, 1979.
5. Lee YN, Lee HY, Chung HY, Kim SI, Lee SK, Park BC and Kim KW: In vitro induction of differentiation by ginsenosides in F9 teratocarcinoma cells. Eur J Cancer 32: 1420-1428, 1996.
6. Odashima S, Ohta T, Kohno H, Matsuda T, Kitagawa I, Abe H and Arichi S: Control of phenotypic expression of cultured B16 melanoma cells by plant glycosides. Cancer Res 45: 2781-2784, 1985.
7. kip1. Cancer Lett 110: 193-200, 1996.
8. Park JA, Lee KY, Oh YJ, Kim KW and Lee SK: Activation of caspase-3 protease via a Bcl-2-insensitive pathway during the process of ginsenoside Rh2-induced apoptosis. Cancer Lett 121: 73-81, 1997.
9. Sherr C and Roberts JM: Inhibitors of mammalian G1 cyclin-dependent kinases. Genes Dev 9: 1149-1163, 1995.
10. Pines J: Cyclins and cyclin-dependent kinases: a biochemical view. Biochem J 308: 679-711, 1995.
11. Nigg EA: Cyclin-dependent protein kinases: key regulators of the eukaryotic cell cycle. Bioessays 17: 471-480, 1995.
12. Matsushime H, Quelle DE, Shurtleff SA, Shibuya M, Sherr CJ and Kato JY: D-type cyclin-dependent kinase activity in mammalian cells. Mol Cell Biol 14: 2066-2076, 1994.
13. Morgan DO: Principles of CDK regulation. Nature 374: 131-134, 1995.
14. Dulic V, Drullinger LF, Lees E, Reed SI and Stein GH: Altered regulation of Gl cyclins in senescent human diploid fibroblasts: accumulation of inactive cyclin E-Cdk2 and cyclin D1-Cdk2 complexes. Proc Natl Acad Sci USA 90: 11034-11038, 1993.
15. Ohtsubo M, Theodoras AM, Schumacher J, Robert JM and Pagano M: Human cyclin E, a nuclear protein essential for G1 to S phase transition. Mol Cell Biol 15: 2612-2624, 1995.
16. Lukas J, Pagano M, Staskova Z, Draetta G and Bartek J: Cyclin D1 protein oscillates and is essential for cell cycle progression in human tumor cell lines. Oncogene 9: 707-718, 1994.
17. Muller H, Lukas J, Schneider A, Warthoe P, Bartek J, Eilers M and Strauss M: Cyclin D1 expression is regulated by the retinoblastoma protein. Proc Natl Acad Sci USA 91: 2945-2949, 1994.
18. Tam SW, Theodoras AM, Shay JW, Draetta GF and Pagano M: Differential expression and regulation of cyclin D1 protein in normal and tumor human cells: association with Cdk4 is required for cyclin D1 function in G1 progeression. Oncogene 9: 2663-2764, 1994.
19. Harper JW and Elledge SJ: Cdk inhibitors in development and cancer. Curr Opin Genet Dev 6: 56-64, 1996.
20. Flores-Rozas H, Kelman Z, Dean FB, Pan ZQ, Harper JW, Elledge SJ, O'Donnell M and Hurwitz J: Cdk-interacting protein 1 directly binds with proliferating cell nuclear antigen and inhibits replication catalyzed by the DNA polymerase delta holoenzyme. Proc Natl Acad Sci USA 91: 8655-8659, 1994.
21. Harper JW, Elledge SJ, Keyomarsi K, Dynlacht B, Tsai LH, Zhang P, Dobrowolski S, Bai C, Connell-Crowley L, Swindall E, Fox MP and Wei N: Inhibition of cyclin-dependent kinase by p21. Mol Biol Cell 6: 387-400, 1995.
22. WAF1 and proliferating cell nuclear antigen. Curr Biol 5: 275-282, 1995.
23. Steinman RA, Hoffman B, Iro A, Guillouf C, Liebermann DA and El-Houseini ME: Induction of p21 (WAF-1/CIP1) during differentiation. Oncogene 9: 3389-3396, 1994.
24. Cox LS and Lane DP: Tumour suppressors, kinases and clamps: how p53 regulates the cell cycle in response to DNA damage. Bioessays 17: 501-508, 1995.
25. Michieli P, Chedid M, Lin D, Pierce JH, Mercer WE and Givol D: Induction of WAF/CIP1 by a p53-independent pathway. Cancer Res 54: 3391 -3395, 1994.
26. Zeng YX and El-Deiry WS: Regulation of p21WAF1/CIP1 expression by p53-independent pathways. Oncogene 12: 1557-1564, 1996.
27. Alpan RS and Pardee AB: p21WAF1/CIP1/SDI1 is elevated through a p53-independent pathway by mimosine. Cell Growth Differ 7: 893-901, 1996.
28. WAF1/CIP1 gene by retinoic acid receptor. J Biol Chem 271: 31723-31728, 1996.
29. Zezula J, Sexl V, Hutter C, Karel A, Schutz W and Freissmuth M: The cyclin-dependent kinase inhibitor p21Cip mediates the growth inhibitory effect of phorbol esters in human venous endothelial cells. J Biol Chem 272: 29967-29974, 1997.
30. Weinberg RA: The retinoblastoma protein and cell cycle control. Cell 81: 323-330, 1995.
31. Adnane J, Shao Z and Robbins PD: The retinoblastoma susceptibility gene product represses transcription when directly bound to the promoter. J Biol Chem 270: 8837-8843, 1995.